Impact of Carbonyl Reductase 3 Genotype Status on Echocardiographic Measurements of Cardiomyopathy in Breast Cancer Patients Treated with Anthracyclines
Description: 

The aim of this prospective study is to examine whether the CBR3 V244M genotype status is associated with changes in 3 sensitive echocardiographic measures of cardiomyopathy in breast cancer patients being treated with standard dose anthracyclines.

Study Number: 

I 219812

Phase: 
Pilot
Principal Investigator: 

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.